Trademark: 90751872
Word
VLE
Status Date
Wednesday, February 7, 2024
Filing Date
Thursday, June 3, 2021
Published for Opposition
Tuesday, March 29, 2022
5 Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, neurological, respiratory, psychiatric, allergic, dermatological, pulmonary, metabolic, muscular, erectile dysfunction, infectious and inflammatory conditions, cancer, diabetes, multiple sclerosis; oral contraceptives
The mark consists of a three-dimensional configuration of the goods, specifically, "VLE" in the center of the pill. The broken dotted lines are not part of the mark but serves only to show the placement of the mark.
Feb 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2024
Sou Extension 3 Granted
Nov 24, 2023
Sou Extension 3 Filed
Feb 5, 2024
Case Assigned To Intent To Use Paralegal
Dec 15, 2023
Notice Of Revival - E-Mailed
Dec 15, 2023
Sou Extension Received With Teas Petition
Dec 15, 2023
Notice Of Revival - E-Mailed
Dec 15, 2023
Petition To Revive-Granted
Dec 15, 2023
Teas Petition To Revive Received
May 25, 2023
Notice Of Approval Of Extension Request E-Mailed
May 23, 2023
Sou Extension 2 Granted
May 23, 2023
Sou Extension 2 Filed
May 23, 2023
Sou Teas Extension Received
Nov 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 14, 2022
Sou Extension 1 Granted
Nov 14, 2022
Sou Extension 1 Filed
Nov 14, 2022
Sou Teas Extension Received
May 24, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 29, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 29, 2022
Published For Opposition
Mar 9, 2022
Notification Of Notice Of Publication E-Mailed
Feb 23, 2022
Approved For Pub - Principal Register
Feb 18, 2022
Assigned To Examiner
Aug 27, 2021
Notice Of Design Search Code E-Mailed
Aug 26, 2021
New Application Office Supplied Data Entered
Jun 7, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
